References
P. Aaby. 1988. Malnutrition and Overcrowding/Intensive Exposure in Severe Measles Infection: Review of Community Studies Reviews of Infectious Diseases 10: 478 - 91 (PubMed)
P. Aaby and C. J. Clements. 1989. Measles Immunization Research: A Review Bulletin of the World Health Organization 67: 443 - 48 (PubMed)
Africa Measles Partnership. 2004. "Measles Investment Case." Board of the Global Alliance for Vaccines and Immunization. http://www.vaccinealliance.org/resources/Measles_Investment_Case_FINAL_w_addendum.pdf.
K. Batt, J. Fox-Rushby and M. Castillo-Riquelme. 2004. The Costs, Effect, and Cost-Effectiveness of Strategies to Increase Coverage of Routine Immunizations in Low- and Middle-Income Countries: Systematic Review of the Grey Literature Bulletin of the World Health Organization 82: 689 - 96 (PubMed)
R. P. Beasley. 1988. Hepatitis B Virus: The Major Etiology of Hepatocellular Carcinoma Cancer 61: 1942 - 56 (PubMed)
Bennett, J. V., A. E. Platonov, M. P. E. Slack, P. Mala, A. H. Burton, and S. E. Robertson. 2002. Haemophilus influenzae Type B (Hib) Meningitis in the Pre-vaccine Era: A Global Review of Incidence, Age Distributions, and Case-Fatality Rates. WHO/V&B/02.18. Geneva: World Health Organization. http://www.who.int/vaccines-documents/DocsPDF02/www696.pdf.
P. Berman, J. Quinley, B. Yusuf, S. Anwar, U. Mustaini, A. Azof and B. Iskandar. 1991. Maternal Tetanus Immunization in Aceh Province, Sumatra: The Cost-Effectiveness of Alternative Strategies Social Science and Medicine 33: 185 - 92 (PubMed)
P. Beutels. 1998. Economic Evaluations Applied to HB Vaccination: General Observations Vaccine 16: S84 - 92 (PubMed)
———2001. Economic Evaluations of Hepatitis B Immunization: A Global Review of Recent Studies (1994-2000) Health Economics 10: 751 - 74 (PubMed)
Birmingham, M., and C. Stein. 2003. "The Burden of Vaccine-Preventable Diseases." In The Vaccine Book, ed. B. R. Bloom and P.-H. Lambert, 1-21. San Diego, CA: Elsevier.
Birmingham, M., L. Wolfson, M. Kurian, U. Griffiths, F. Gasse, and J. Vandelaer. 2004. "Estimating the Burden of Neonatal Tetanus." Unpublished manuscript.
Brenzel, L. 1995. "Final Report on the Longitudinal Cost-Effectiveness Study of the North Arcot District Polio Control Program (NADPCP)." Resources for Child Health Project, U.S. Agency for International Development, Arlington, VA.
———. 2005. "Methods Used to Estimate the Costs of Scaling Up Immunization Services for the Vaccine Preventable Disease Chapter, Disease Control Priorities Project." World Bank, Washington, DC.
L. Brenzel and P. Claquin. 1994. Immunization Programs and Their Costs Social Science and Medicine 39: 527 - 36 (PubMed)
R. Brinsmead, S. Hill and D. Walker. 2004. Are Economic Evaluations of Vaccines Useful to Decision Makers? Case Study of Haemophilus Influenzae Type B Vaccines Pediatric Infectious Disease Journal 23: 32 - 37 (PubMed)
Cherry, J. D., and R. E. Harrison. 2004. "Tetanus." In Textbook of Pediatric Infectious Diseases, ed. R. D. Feigin, J. D. Cherry, G. J. Demmler, and S. L. Kaplan, 1766-76. Philadelphia: Elsevier.
Cherry, J. D., and U. Heininger. 2004. "Pertussis and Other Bordetella Infections." In Textbook of Pediatric Infectious Diseases, ed. R. D. Feigin, J. D. Cherry, G. J. Demmler, and S. L. Kaplan, 1588-1608. Philadelphia: Elsevier.
A. L. Creese. 1986. Cost-Effectiveness of Potential Immunization Interventions against Diarrheal Disease Social Science and Medicine 23: 231 - 40 (PubMed)
A. L. Creese and M. A. Dominguez-Uga. 1987. Cost-Effectiveness of Immunization Programs in Colombia Pan American Health Organization Bulletin 21: 377 - 94
N. S. Crowcroft, C. Stein, P. Duclos and M. Birmingham. 2003. How Best to Estimate the Global Burden of Pertussis? Lancet Infectious Diseases 3: 413 - 18 (PubMed)
D. Ding, P. E. Kilgore, J. D. Clemens, L. Wei and X. Zhi-Yi. 2003. Cost-Effectiveness of Routine Immunization to Control Japanese Encephalitis in Shanghai, China Bulletin of the World Health Organization 81: 334 - 42 (PubMed)
M. A. Dominguez-Uga. 1988. Economic Analysis of the Vaccination Strategies Adopted in Brazil in 1982 Bulletin of the World Health Organization 22: 250 - 68
D. J. Edmunds, A. Dejene, Y. Mekkonen, M. Haile, W. Alemnu and D. J. Nokes. 2000. The Cost of Integrating Hepatitis B Virus Vaccine into National Immunization Programs: A Case Study from Addis Ababa Health Policy and Planning 15: 408 - 16 (PubMed)
Edwards, K. M., and M. D. Decker. 2004. "Pertussis Vaccine." In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 471-528. Philadelphia: Saunders.
E. H. Elbasha and M. L. Messonnier. 2004. Cost-Effectiveness Analysis and Health Care Resource Allocation: Decision Rules under Variable Returns to Scale Health Economics 13: 21 - 35 (PubMed)
Feigin, R. D., B. W. Stechenberg, and P. Hertel. 2004. "Diphtheria." In Textbook of Pediatric Infectious Diseases, ed. R. D. Feigin, J. D. Cherry, G. J. Demmler, and S. L. Kaplan, 1305-13. Philadelphia: Elsevier.
Foster, S. O., D. A. McFarland, and A. M. John. 1993. "Measles." In Disease Control Priorities in Developing Countries, ed. D. T. Jamison, W. H. Mosley, A. R. Measham, and J. L. Bobadilla, 161-87. New York: Oxford University Press and World Bank. http://www.fic.nih.gov/dcpp/dcp1/dcp1-ch8.pdf.
J. A. Fox-Rushby, M. Kaddar, R. Levine and L. Brenzel. 2004. The Economics of Vaccination in Low- and Middle-Income Countries Bulletin of the World Health Organization 82: 640 (PubMed)
Galazka, A., M. Birmingham, M. Kurian, and F. Gasse. Forthcoming. "Tetanus." In The Global Epidemiology of Infectious Disease, ed. C. J. L. Murray and A. D. Lopez. Cambridge, MA: Harvard University Press.
Galazka, A. M., and S. E. Robertson. Forthcoming. "Diphtheria." In The Global Epidemiology of Infectious Diseases, ed. C. J. L. Murray and A. D. Lopez, Cambridge, MA: Harvard University Press.
A. M. Galazka, S. E. Robertson and G. P. Oblapenko. 1995. Resurgence of Diphtheria European Journal of Epidemiology 11: 95 - 105 (PubMed)
GAVI (Global Alliance for Vaccines and Immunization). 2004. "Guidelines for Preparing a National Immunization Financial Sustainability Plan." Geneva, GAVI. http://www.who.int/immunization_financing/tools/en/FSP_Guidelines_April%202004_En.pdf.
Gay, N. J., W. J. Edmunds, E. Bah, and C. B. Nelson. 2001. Estimating the Global Burden of Hepatitis B. Geneva: World Health Organization.
B. D. Gessner, A. Sutanto, M. Linehan, I. G. G. Djelantik, T. Fletcher, K. Ingerani , et al. , et al.. 2005. The Incidence of Vaccine-Preventable Haemophilus influenzae Type B Pneumonia and Meningitis in Indonesian Children Using a Hamlet-Randomized Vaccine Probe Design Lancet 365: 9453 43 - 52 (PubMed)
M. Golden and G. L. Shapiro. 1984. Cost-Benefit Analysis of Alternative Programs of Vaccination against Rubella in Israel Public Health 98: 179 - 90 (PubMed)
A. H. Griffith. 1979. The Role of Immunization in the Control of Diphtheria Developments in Biological Standards 43: 3 - 13
U. K. Griffiths, G. Hutton and E. D. Pascoal. 2005. The Cost-Effectiveness of Introducing Hepatitis B Vaccine into Infant Immunization Services in Mozambique Health Policy Plan 20: 1 50 - 59 (PubMed)
U. K. Griffiths, L. J. Wolfson, A. Quddus, M. Younus and R. A. Hafiz. 2004. Incremental Cost-Effectiveness of Supplementary Immunization Activities to Prevent Neo-natal Tetanus in Pakistan Bulletin of the World Health Organization 82: 643 - 51 (PubMed)
Hadler, S. C., S. L. Cochi, J. Bilous, and F. T. Cutts. 2004. "Vaccination Programs in Developing Countries." In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 1407-42. Philadelphia: Saunders.
N. A. Halsey, M. Blatter, G. Bader, M. L. Thoms, F. F. Willingham, J. C. O'Donovan , et al. , et al.. 1997. Inactivated Poliovirus Vaccine Alone or Sequential Inactivated and Oral Poliovirus Vaccine in Two-, Four-, and Six-Month-Old Infants with Combination Haemophilus influenzae Type B/Hepatitis B Vaccine Pediatric Infectious Disease Journal 16: 675 - 79 (PubMed)
N. Halsey and A. Galazka. 1985. The Efficacy of DPT and Oral Poliomyelitis Immunization Schedules Initiated from Birth to 12 Weeks of Age Bulletin of the World Health Organization 63: 6 1151 - 69 (PubMed)
R. H. Henderson and T. Sundaresan. 1982. Cluster Sampling to Assess Immunization Coverage: A Review of Experience with a Simplified Sampling Method Bulletin of the World Health Organization 60: 253 - 60 (PubMed)
A. R. Hinman, B. Irons, M. Lewis and K. Kandola. 2002. Economic Analyses of Rubella and Rubella Vaccines: A Global Review Bulletin of the World Health Organization 80: 264 - 70 (PubMed)
G. Karlsson and M. Johannesson. 1998. Cost-Effectiveness Analysis and Capital Costs Social Science and Medicine 46: 1183 - 91 (PubMed)
Khaleghian, P. 2001. "Immunization Financing and Sustainability: A Review of the Literature." Special Initiatives Report 40. Bethesda, MD: Partnerships for Health Reform Project, Abt Associates.
S. Krugman. 1963. Measles and Poliomyelitis Vaccines New York State Journal of Medicine 63: 2973 - 77
Levin, A., S. England, J. Jorissen, B. Garshong, and J. Teprey. 2001. Case Study on the Costs and Financing of Immunization Services in Ghana. Report by PHR plus. Bethesda, MD: Abt Associates.
M. M. Levine, R. Lagos, O. S. Levine, I. Heitmann, N. Enriquez, M. E. Pinto , et al. , et al.. 1998. Epidemiology of Invasive Pneumococcal Infections in Infants and Young Children in Metropolitan Santiago, Chile, a Newly Industrializing Country Pediatric Infectious Disease Journal 17: 287 - 93 (PubMed)
Lydon, P. 2004. "Financial Sustainability Plan Analysis: A Look across 22 GAVI Countries." World Health Organization, Geneva.
Margolis, H. S., M. J. Alter, and S. C. Hadler. 1997. "Viral Hepatitis." In Viral Infections of Humans: Epidemiology and Control, ed. A. S. Evans and R. A. Kaslow, 363-418. New York: Plenum.
M. Martin, J. M. Casellas, S. A. Madhi, T. J. Urquhart, S. D. Delport, F. Ferrero , et al. , et al.. 2004. Impact of Haemophilus influenzae Type B Conjugate Vaccine in South Africa and Argentina Pediatric Infectious Disease Journal 23: 842 - 47 (PubMed)
Mast, E., F. Mahoney, M. A. Kane, and H. S. Margolis. 2004. "Hepatitis B Vaccine." In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 299-338. Philadelphia: Saunders.
Mathers, C. D., A. D. Lopez, and C. J. L. Murray. 2006. "The Burden of Disease and Mortality by Condition: Data, Methods, and Results for the Year 2001." In Global Burden of Disease and Risk Factors. ed. Alan D. Lopez, Colin D. Mathers, Majid Ezzati, Dean T. Jamison, and Christopher J. L. Murray. New York: Oxford University Press.
G. M. McQuillan, P. J. Coleman, D. Kruszon-Moran, L. A. Moyer, S. B. Lambert and H. S. Margolis. 1999. Prevalence of Hepatitis B Virus Infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994 American Journal of Public Health 89: 14 - 18 (PubMed)
M. A. Miller. 1998. An Assessment of the Value of Haemophilus influenzae Type B Conjugate Vaccine in Asia Pediatric Infectious Disease Journal 17: S152 - 59 (PubMed)
M. A. Miller and L. McCann. 2000. Policy Analysis of the Use of Hepatitis B, Haemophilus influenzae Type B-, Streptococcus pneumoniae-Conjugate, and Rotavirus Vaccines in National Immunization Schedules Health Economics 9: 19 - 35 (PubMed)
M. A. Miller, S. C. Redd, S. Hadler and A. Hinman. 1998. A Model to Estimate the Potential Economic Benefits of Measles Eradication for the United States Vaccine 20: 1917 - 22
M. A. Miller, R. W. Sutter, P. M. Strebel and S. C. Hadler. 1996. Cost-Effectiveness of Incorporating Inactivated Poliovirus Vaccine into the Routine Childhood Immunization Schedule Journal of the American Medical Association 276: 967 - 71 (PubMed)
Monath, T. P. 2004. "Yellow Fever Vaccine." In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 1095-176. Philadelphia: Saunders.
T. P. Monath, R. B. Craven, A. Adjukiewicz, M. Germain, D. B. Francy, L. Ferrara , et al. , et al.. 1980. Yellow Fever in The Gambia, 1978-79: Epidemiologic Aspects with Observations on the Occurrence of Orungo Virus Infections American Journal of Tropical Medicine and Hygiene 29: 912 - 28 (PubMed)
S. S. Morris, R. E. Black and L. Tomaskovic. 2003. Predicting the Distribution of Under-Five Deaths by Cause in Countries without Adequate Vital Registration Systems International Journal of Epidemiology 32: 1041 - 51 (PubMed)
W. J. Moss, C. J. Clements and N. A. Halsey. 2003. Immunization of Children at Risk of Infection with Human Immunodeficiency Virus Bulletin of the World Health Organization 81: 61 - 70 (PubMed)
K. Mulholland, S. Hilton, R. Adegbola, S. Usen, A. Oparaugo, C. Omosigho , et al. , et al.. 1997. Randomised Trial of Haemophilus influenzae Type B Tetanus Protein Conjugate Vaccine [Corrected] for Prevention of Pneumonia and Meningitis in Gambian Infants Lancet 349: 1191 - 97 (PubMed)
Mulligan, J.-A., J. A. Fox-Rushby, T. Adam, B. Johns, and A. Mills. 2003. "Unit Costs of Health Care Inputs in Low- and Middle-Income Regions." Disease Control Priorities Project Working Paper 9. DCPP, National Institutes of Health, Bethesda, MD. http://www.fic.nih.gov/dcpp/wpb9.pdf.
A. Nasidi, T. P. Monath, K. DeCock, O. Tomori, R. Cordellier, O. D. Olaleye , et al. , et al.. 1989. Urban Yellow Fever Epidemic in Western Nigeria, 1987 Transactions of the Royal Society of Tropical Medicine and Hygiene 83: 401 - 6 (PubMed)
NIH (National Institutes of Health). 2000. "Jordan Report 20th Anniversary: Accelerated Development of Vaccines." http://www.niaid.nih.gov/dmid/vaccines/jordan20/. NIH, Bethesda.
E. Pegurri, J. Fox-Rushby and D Walker. 2005. The Effects and Costs of Expanding Coverage of Immunization Services in Developing Countries: A Systematic Literature Review Vaccine 23: 1624 - 35 (PubMed)
H. Peltola. 2000. Worldwide Haemophilus influenzae Type B Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of Conjugates Clinical Microbiology Reviews 13: 302 - 17 (PubMed)
Perry, R. T. Forthcoming.
R. T. Perry and N. A. Halsey. 2004. The Clinical Significance of Measles: A Review Journal of Infectious Diseases 189: Suppl. 1 S4 - 16 (PubMed)
Plotkin, S. A., and E. Vidor. 2004. "Poliovirus Vaccine: Inactivated." In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 625-50. Philadelphia: Saunders.
R. L. Robertson, A. J. Hall, P. E. Crivelli, Y. Lowe, H. M. Inskip and S. K. Snow. 1992. Cost-Effectiveness of Immunizations: The Gambia Revisited Health Policy and Planning 7: 111 - 22
Robertson, S. E. 1993. The Immunological Basis for Immunization Series Module 6: Poliomyelitis. WHO/EPI/GEN/93.16. Geneva: World Health Organization.
N. Sangrugee, V. Caceres and S. Cochi. 2004. Cost Analysis of Post-polio Certification Immunization Policies Bulletin of the World Health Organization 82: 9 - 15 (PubMed)
T. Siraprapasiri, W. Sawaddiwudhipong and S. Rojanasuphot. 1997. Cost-Benefit Analysis of Japanese Encephalitis Vaccination Program in Thailand Southeast Asian Journal of Tropical Medicine and Public Health 28: 143 - 48
A. Soucat, D. Levy-Bruhl, X. De Bethune, P. Gbedonou, J.-P. Lamarque, O. Bangoura , et al. , et al.. 1997. Affordability, Cost-Effectiveness, and Efficiency of Primary Health Care: The Bamako Initiative Experience in Benin and Guinea International Journal of Health Planning and Management 12: S81 - 108 (PubMed)
J. P. Stanfield and A. Galazka. 1984. Neonatal Tetanus in the World Today Bulletin of the World Health Organization 62: 647 - 69 (PubMed)
C. E. Stein, M. Birmingham, M. Kurian, P. Duclos and P. Strebel. 2003. The Global Burden of Measles in the Year 2000: A Model That Uses Country-Specific Indicators Journal of Infectious Diseases 187: Suppl. 1 S8 - 15 (PubMed)
Steinglass, R., L. Brenzel, and A. Percy. 1993. "Tetanus." In Disease Control Priorities in Developing Countries, ed. D. T. Jamison, W. H. Mosley, A. R. Measham, and J. L. Bobadilla, 189-220. New York: Oxford University Press and World Bank.
Sutter, R. W., and O. M. Kew. 2004. "Poliovirus Vaccine: Live." In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 651-706. Philadelphia: Saunders.
M. N. Swartz. 2004. Bacterial Meningitis: A View of the Past 90 Years New England Journal of Medicine 351: 1826 - 28 (PubMed)
Turk, D. C. 1982. "Clinical Importance of Haemophilus influenzae: 1981." In Haemophilus influenzae, ed. S. H. Sell and P. G. Wright, 3-9. New York: Elsevier.
UNICEF (United Nations Children's Fund). 2002. State of the World's Vaccines and Immunization. New York: United Nations.
USAID (U.S. Agency for International Development), Asia-Near East Region. 1988. "Resources for Child Health Project." Asia-Near East Bureau Guidance for Costing of Health Services Delivery Projects, Arlington, VA.
V. Valdmanis, D. Walker and J. Fox-Rushby. 2003. Are Vaccination Sites in Bangladesh Scale Efficient? International Journal of Technology Assessment in Health Care 19: 692 - 97 (PubMed)
D. Walker, N. R. Mosqueira, M. E. Penny, C. F. Lanata, A. D. Clark, C. F. B. Sanderson and J. Fox-Rushby. 2004. Variation in the Costs of Delivering Routine Immunization Services in Peru Bulletin of the World Health Organization 82: 676 - 82 (PubMed)
Wassilak, S, G. F. Trudy, V. Murphy, M. H. Roper, and W. A. Orenstein. 2004."Tetanus Toxoid."In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 745-82. Philadelphia: Saunders.
Wenger, J. D., and J. Ward. 2004. "Haemophilus influenzae Vaccine." In Vaccines, ed. S. A. Plotkin and W. A. Orenstein, 229-68. Philadelphia: Saunders.
WHO (World Health Organization). 1974. Handbook of Resolutions. Vol. 1, 1.8. World Health Assembly, Fourteenth plenary meeting, 23 May 1974. Geneva: WHO.
———. 1988. EPICost. Geneva: WHO.
———. 1992. Global Health Situation and Projections: Estimates. WHO/HST/92.1. Geneva: WHO. whqlibdoc.who.int/hq/1992/WHO_HST_92.1.pdf.
———. 1996. "HBsAG Endemicity." http://wwwstage/vaccines-surveillance/graphics/htmls/hepbprev.htm. WHO, Geneva.
———. 2001. Estimating the Local Burden of Haemophilus influenzae Type b (Hib) Disease Preventable by Vaccination: A Rapid Assessment Tool. WHO/V&B/01.27. Geneva: WHO.
———. 2002. Core Information for the Development of Immunization Policy, 2002 Update. WHO/V&B/02.28. Geneva: WHO. http://www.who.int/vaccines-documents/DocsPDF02/www557.pdf.
———. 2004. "Progress toward Global Immunization Goals, 2001." http://www.who.int/vaccines/. WHO, Geneva.
———2005a. Progress in Reducing Global Measles Deaths: 1999-2003 Weekly Epidemiological Record 80: 9 78 - 81 (PubMed)
———. 2005b. World Health Report 2005: Make Every Mother and Child Count. Geneva: WHO.
Wolfson, L., and P. Lydon. 2005. "Methodology for Estimating Baseline and Future Levels of Costing (and Impact) for the Global Immunization Vision and Strategy 2005-2015, Draft 1.1." World Health Organization, Geneva.
World Bank. 1993. Investing in Health: World Development Report, 1993. New York: Oxford University Press.
